Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06203756

Patient Outcomes With Robotic-Assisted Total Knee Arthroplasty

Improved Patient Outcomes With Robotic-Assisted Total Knee Arthroplasty

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
713 (estimated)
Sponsor
Corin · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This is a post-market multicentre study that has been implemented to confirm safety and performance of cemented CR/UC and PS Apex Knee implants in primary or revision Robotic Assisted Total Knee Arthroplasty up to 10-year follow up.

Detailed description

This study has been implemented to confirm safety and performance of cemented CR/UC and PS Apex Knee implants in primary or revision RA-TKA up to 10-year follow up. Prospective data will be collected for this Post Market Clinical Follow up (PMCF) study and the data will be fed into the Post-Market Surveillance (PMS) and Clinical Evaluation processes of the devices under assessment on annual basis and support presentations at orthopaedic congresses and/or peer-reviewed publication(s). Participants will be selected for recruitment into the study from the general population of participants requiring a primary or revision knee-arthroplasty and considered suitable to receive the Apex Knee System.

Conditions

Interventions

TypeNameDescription
DEVICEOmnibotics Robotic-assisted Total Knee Arthroplasty with Apex UCRobotic-assisted total knee arthroplasty in femur and tibial first workflows using the BalanceBot to characterize soft tissue balance, and the Apex UltraCongruent (UC) knee implant type
DEVICEOmnibotics Robotic-assisted Total Knee Arthroplasty with Apex PSRobotic-assisted total knee arthroplasty with a tibial first workflow using the BalanceBot to characterize soft tissue balance, and the Apex PosteriorStabilized (PS) knee implant type
DEVICEOmnibotics Robotic-assisted Total Knee Arthroplasty with Apex RevisionRobotic-assisted total knee arthroplasty with a tibial first workflow using the BalanceBot to characterize soft tissue balance, and the Apex Revision knee implant type

Timeline

Start date
2017-11-09
Primary completion
2029-01-01
Completion
2040-04-01
First posted
2024-01-12
Last updated
2025-05-20

Locations

6 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06203756. Inclusion in this directory is not an endorsement.